Full-Length Semaphorin-3C Is an Inhibitor of Tumor Lymphangiogenesis and Metastasis

信号灯 生物 血管生成 癌症研究 转移 免疫学 癌症 受体 遗传学
作者
Yelena Mumblat,Ofra Kessler,Neta Ilan,Gera Neufeld
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:75 (11): 2177-2186 被引量:67
标识
DOI:10.1158/0008-5472.can-14-2464
摘要

Abstract Semaphorins play important regulatory roles in diverse processes such as axon guidance, angiogenesis, and immune responses. We find that semaphorin-3C (sema3C) induces the collapse of the cytoskeleton of lymphatic endothelial cells (LEC) in a neuropilin-2-, plexin-D1-, and plexin-A1–dependent manner, while most other semaphorins, including antiangiogenic semaphorins such as sema3A do not. Sema3C is cleaved, like other class-3 semaphorins, by furin-like pro-protein convertases (FPPC). Cleaved sema3C (p65-Sema3C) was unable to induce the collapse of the cytoskeleton of LEC. FPPC are strongly upregulated in tumor cells. In order to examine the effects of full-length sema3C on tumor progression, we therefore generated an active point mutated furin cleavage-resistant sema3C (FR-sema3C). FR-sema3C inhibited potently proliferation of LEC and to a lesser extent proliferation of human umbilical vein–derived endothelial cells. FR-sema3C also inhibited VEGF-C–induced phosphorylation of VEGFR-3, ERK1/2, and AKT. Expression of recombinant FR-sema3C in metastatic, triple-negative LM2-4 breast cancer cells did not affect their migration or proliferation in vitro. However, tumors derived from FR-sema3C–expressing LM2-4 cells implanted in mammary fat pads developed at a slower rate, contained a lower concentration of blood vessels and lymph vessels, and metastasized much less effectively to lymph nodes. Interestingly, p65-Sema3C, but not FR-sema3C, rendered A549 lung cancer cells resistant to serum deprivation, suggesting that previously reported protumorigenic activities of sema3C may be due to p65-Sema3C produced by tumor cells. Our observations suggest that FR-sema3C may be further developed into a novel antitumorigenic drug. Cancer Res; 75(11); 2177–86. ©2015 AACR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Cat完成签到,获得积分0
1秒前
嘎嘎嘎嘎发布了新的文献求助10
1秒前
starofjlu应助夜雨采纳,获得20
2秒前
huiyuan发布了新的文献求助10
2秒前
李爱国应助齐大风采纳,获得10
5秒前
qqesk完成签到,获得积分10
5秒前
7秒前
7秒前
斯文败类应助危机的芸采纳,获得30
7秒前
7秒前
qqesk发布了新的文献求助10
7秒前
七七完成签到,获得积分10
8秒前
huiyuan完成签到,获得积分10
8秒前
8秒前
李李发布了新的文献求助30
8秒前
lzy发布了新的文献求助10
9秒前
任逍遥完成签到,获得积分10
10秒前
10秒前
折枝星发布了新的文献求助10
10秒前
七七发布了新的文献求助10
11秒前
ZZZZZZZZF发布了新的文献求助10
11秒前
人不犯二枉少年完成签到,获得积分20
11秒前
科研通AI2S应助科研通管家采纳,获得10
12秒前
烟花应助科研通管家采纳,获得10
12秒前
脑洞疼应助科研通管家采纳,获得10
12秒前
12秒前
星希应助科研通管家采纳,获得10
12秒前
完美世界应助科研通管家采纳,获得10
12秒前
12秒前
共享精神应助科研通管家采纳,获得10
12秒前
小蘑菇应助科研通管家采纳,获得10
12秒前
在水一方应助科研通管家采纳,获得10
13秒前
ShowMaker应助科研通管家采纳,获得30
13秒前
星希应助科研通管家采纳,获得10
13秒前
小马甲应助科研通管家采纳,获得10
13秒前
ShowMaker应助科研通管家采纳,获得30
13秒前
13秒前
夏夏1992发布了新的文献求助10
15秒前
星辰大海应助无与伦比采纳,获得10
15秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
An Introduction to Geographical and Urban Economics: A Spiky World Book by Charles van Marrewijk, Harry Garretsen, and Steven Brakman 500
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3151736
求助须知:如何正确求助?哪些是违规求助? 2803153
关于积分的说明 7852024
捐赠科研通 2460525
什么是DOI,文献DOI怎么找? 1309844
科研通“疑难数据库(出版商)”最低求助积分说明 629061
版权声明 601760